Biofrontera Inc. Profile Avatar - Palmy Investing

Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in co…

Drug Manufacturers - Specialty & Generic
US, Woburn [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of BFRI's Analysis
CIK: 1858685 CUSIP: 09077D100 ISIN: US09077D2099 LEI: - UEI: -
Secondary Listings
BFRI has no secondary listings inside our databases.